 BOSTON, Jan. 07, 2021 GLOBE NEWSWIRE -- Albireo Pharma, Inc. Nasdaq: ALBO, a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST. 